Ms Sherlena Elizabeth Roach, CERT SOCIAL WORKER | |
1104 4th St Ste D, Gretna, LA 70053-5909 | |
(504) 262-8884 | |
(504) 309-9066 |
Full Name | Ms Sherlena Elizabeth Roach |
---|---|
Gender | Female |
Speciality | Case Manager/care Coordinator |
Location | 1104 4th St Ste D, Gretna, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881105369 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Sherlena Elizabeth Roach, CERT SOCIAL WORKER 2736 A P Tureaud Ave, New Orleans, LA 70119-1126 Ph: (504) 701-9181 | Ms Sherlena Elizabeth Roach, CERT SOCIAL WORKER 1104 4th St Ste D, Gretna, LA 70053-5909 Ph: (504) 262-8884 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Virtual reality isn't just for gaming. Researchers can use virtual reality, or VR, to assess participants' attention, memory and problem-solving abilities in real world settings.
Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its new balloon expandable stent for renal artery disease. Intended for patients suffering from renal artery stenosis, a narrowing of the arteries that supply blood to the kidneys, the new device features a low profile design and does not shorten upon expansion.
Researchers at Wayne State University have tested a breast cancer vaccine they say completely eliminated HER2-positive tumors in mice - even cancers resistant to current anti-HER2 therapy - without any toxicity.
› Verified 9 days ago